聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 19 分钟 28 秒 前

Synlogic Secures $29.4 Million Series A Financing Led by Atlas Venture and New Enterprise Associates

周二, 07/22/2014 - 13:44
First-in-class, proprietary synthetic biology platform leveraged for application across multiple diseases CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Synlogic, Inc., a biotechnology company focused on the development of therapeutic microbe...
Biopharmaceuticals, Venture Capital
Synlogic, microbial engineering

Teleflex Receives FDA Clearance for ARROW-Clark(TM) VectorFlow(TM) Chronic Hemodialysis Catheter

周二, 07/22/2014 - 13:38
WAYNE, Pa.--(Healthcare Sales & Marketing Network)--Teleflex Incorporated (TFX), a leading global provider of medical devices for critical care and surgery, has announced it has received FDA 510(k) clearance to market its ARROW-Clark™ VectorFlow™ Chronic H...
Devices, FDA
Teleflex, ARROW-Clark, VectorFlow, Hemodialysis Catheter

Covidien Announces Leadership Appointment

周二, 07/22/2014 - 13:33
DUBLIN, Ireland--(Healthcare Sales & Marketing Network)--Covidien plc (COV) today announced that Bryan Hanson, who currently serves as group president, Medical Devices & U.S., will be elevated to the newly created position of group president, Covidien, eff...
Devices, Personnel
Covidien

Multi-Center Trial Shows Significant Pain Relief for Spine Cancer Patients Following Targeted Radiofrequency Ablation Treatment

周二, 07/22/2014 - 13:28
SAN JOSE, Calif.--(Healthcare Sales & Marketing Network)--DFINE®, Inc., a market leader in the minimally invasive treatment of spinal diseases, today announced the publication of a multi-center study in the July/August issue of Pain Physician Journal, ...
Devices, Oncology
DFINE Inc, t-RFA, Targeted Radiofrequency Ablation, Tumor Ablation

FDA Grants Genentech’s Avastin Priority Review for Recurrent Platinum-Resistant Ovarian Cancer

周二, 07/22/2014 - 13:21
SOUTH SAN FRANCISCO, Calif.--(Healthcare Sales & Marketing Network)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's supplemental Biologics Lic...
Biopharmaceuticals, Oncology, FDA
Genentech, Avastin, bevacizumab, ovarian cancer

CorMatrix(R) Reports FDA Clearance of CorMatrix ECM(R) for Vascular Repair

周一, 07/21/2014 - 15:17
ROSWELL, Ga.--(Healthcare Sales & Marketing Network)--CorMatrix Cardiovascular announced today that it has received U.S. Food and Drug Administration (FDA) clearance to market the CorMatrix® ECM® for Vascular Repair. The CorMatrix ECM for Vascul...
Devices, Regenerative Medicine, FDA
CorMatrix Cardiovascular, CorMatrix ECM, Vascular Repair

Varian Medical Systems Receives FDA 510(k) Clearance for Calypso(R) Soft Tissue Beacon(R) Transponder

周一, 07/21/2014 - 15:12
New clearance expands the indications for which clinicians will be able to use Varian's Calypso real-time tracking device for monitoring motion during radiotherapy treatments for cancer PALO ALTO, Calif., July 21, 2014 -- (Healthcare Sales & Marketing N...
Devices, Oncology, FDA
Varian Medical Systems, Calypso, soft tissue Beacon, radiotherapy, radiosurgery

Expanding Orthopedics Inc. has obtained FDA Clearance for its FLXfit(TM), the world's first 3D expandable interbody cage

周一, 07/21/2014 - 15:09
EOI announces FDA Clearance of the FLXfit™, the only TLIF cage combining articulation and height expansion with lordotic angle correction. OR AKIVA, Israel, July 21, 2014 -- (Healthcare Sales & Marketing Network) -- Expanding Orthopedics Inc. (EOI), a ...
Devices, Orthopaedic, Neurosurgery, FDA
Expanding Orthopedics, FLXfit, interbody fusion

Zynex Announces Brian Alleman as Chief Financial Officer

周一, 07/21/2014 - 15:05
LONE TREE, CO--(Healthcare Sales & Marketing Network) - Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological d...
Devices, Neurology, Personnel
Zynex, NeuroDiagnostics, electrotherapy

Anacor Pharmaceuticals and Sandoz Enter Into an Agreement for the Commercialization of KERYDIN in the United States

周一, 07/21/2014 - 15:02
Anacor Will Host a Conference Call Today at 8:00 a.m. EDT / 5:00 a.m. PDT PALO ALTO, Calif.--(Healthcare Sales & Marketing Network)--Anacor Pharmaceuticals, Inc. (ANAC) today announced that it has entered into an exclusive agreement with Sandoz Inc., a ...
Biopharmaceuticals, Dermatology, Distribution
Anacor Pharmaceuticals, Sandoz, KERYDINTM, tavaborole

MicroCHIPS, Inc. appoints Cheryl R. Blanchard, Ph.D., as Chief Executive Officer

周一, 07/21/2014 - 15:00
Industry veteran to lead next stage of commercialization for implantable drug delivery devices, with near-term focus on women's health WALTHAM, Mass.--(Healthcare Sales & Marketing Network)--MicroCHIPS, Inc., a developer of implantable drug delivery dev...
Devices, Drug Delivery, Personnel
MicroCHIPS

AngioDynamics Awarded Novation Innovative Technology Contract Covering BioFlo PICCs and BioFlo Ports

周一, 07/21/2014 - 14:56
ALBANY, N.Y., July 21, 2014 -- (Healthcare Sales & Marketing Network) -- AngioDynamics (ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today rece...
Devices, Group Purchasing
AngioDynamics, Novation, PICC

Surgeons of the University Hospital Essen Complete World's First Robotic-Assisted Cancer Surgery with Medrobotics' Flex(R) System

周一, 07/21/2014 - 14:53
ESSEN, Germany--(Healthcare Sales & Marketing Network)--Leading surgeons of the Ear, Nose and Throat Clinic at the University Hospital Essen completed the world’s first robotic-assisted cancer procedures with the Medrobotics’ Flex® System. Professor St...
Devices, Oncology, Surgery
Medrobotics, robotic surgery

Durata Therapeutics Announces the U.S. Launch of DALVANCE(TM)

周五, 07/18/2014 - 12:08
CHICAGO, July 18, 2014 -- (Healthcare Sales & Marketing Network) -- Durata Therapeutics, Inc. (DRTX) announced today that DALVANCE (dalbavancin) for injection is now available for use to treat adult patients with acute bacterial skin and skin structure inf...
Biopharmaceuticals, Product Launch
Durata Therapeutics, DALVANCE, dalbavancin, ABSSSI

Bausch + Lomb's VICTUS(R) Femtosecond Laser Platform Receives 510(k) Clearance from FDA for Lens Fragmentation Procedure

周四, 07/17/2014 - 13:03
LAVAL, Quebec , July 17, 2014 (Healthcare Sales & Marketing Network) -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that its wholly owned subsidiary, Bausch + Lomb has received 510(k) clearance from the U.S. Food an...
Devices, Ophthalmology, FDA
Valeant Pharmaceuticals, Bausch + Lomb, VICTUS , Femtosecond Laser

Edico Genome Raises $10 Million in Series A Financing to Commercialize DRAGEN Chip to Overcome Sequencing Data Analysis Bottleneck

周四, 07/17/2014 - 12:55
Led by Qualcomm, Gregory Lucier Makes First Investment after Leading Life Technologies SAN DIEGO, July 17, 2014 -- (Healthcare Sales & Marketing Network) -- Edico Genome announced today that it has raised $10 million in a Series A financing to commerci...
Devices, Diagnostics, Venture Capital
Edico Genome, DRAGEN Bio-IT Processor

Salix and Pharming Announce FDA Approval of RUCONEST(R) for the Treatment of Acute Angioedema Attacks in Patients with Hereditary Angioedema (HAE)

周四, 07/17/2014 - 12:47
RUCONEST® (C1 Esterase Inhibitor [Recombinant]) 50 IU/kg IS The First and Only Recombinant Treatment Option for Adult and Adolescent Patients Suffering from Hereditary Angioedema RALEIGH, N.C. & LEIDEN, The Netherlands--(Healthcare Sales & Marketin...
Biopharmaceuticals, FDA
Salix Pharmaceuticals, Pharming Group, RUCONEST, hereditary angioedema

Covidien Makes Liver Tumor Ablation More Predictable

周三, 07/16/2014 - 13:09
DUBLIN, Ireland--(Healthcare Sales & Marketing Network)--Overcoming a significant roadblock to predictable ablation of soft tissue, Covidien plc (COV) has unveiled an advanced ablation system that offers physicians predictable results regardless of the tar...
Devices, Surgery, Product Launch
Covidien, Emprint Ablation System, Thermosphere, ablation

Pfizer Announces Positive Top-Line Results From Phase 3 Study Of NONACOG ALFA (BeneFIX(R)) Once-Weekly Prophylaxis For Hemophilia B

周三, 07/16/2014 - 13:02
Once-Weekly Prophylaxis Treatment with BeneFIX® Significantly Reduced Annualized Bleeding Rate Compared to On-Demand Treatment NEW YORK--(Healthcare Sales & Marketing Network)--Pfizer Inc. (PFE) today announced the positive results of a Phase 3 stud...
Biopharmaceuticals
Pfizer, BeneFIX, Factor IX, hemophilia B

Virobay Completes $8 Million Series B Preferred Stock Financing

周三, 07/16/2014 - 12:56
MENLO PARK, Calif., July 16, 2014 -- (Healthcare Sales & Marketing Network) -- Virobay, Inc., a clinical stage pharmaceutical company with a platform of cathepsin protease inhibitors being developed for the treatment of neuropathic pain, autoimmune diseas...
Biopharmaceuticals, Venture Capital
Virobay, VBY-036, neuropathic pain

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong